Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Koninklijke Philips NV (AMS:PHIA)
| Market Cap | 37.40B |
|---|---|
| Revenue | 0 |
| Gross Profit | 0 |
| Shares Out | 0.92B |
| EPS (ttm) | |
| PE Ratio | 0.0000 |
| Forward PE | 0.0000 |
| Dividend Rate (ttm) | 0.8500 |
| Dividend Yield | 0.0209 |
| Trading Day | Jul 23 |
|---|---|
| Last Price | €40.77 |
| Previous Close | €39.98 |
| Change (€) | 0.79 |
| Change (%) | 1.98% |
| Day's Open | 39.975 |
| Day's Range | 38.935 - 40.765 |
| Day's Volume | 0 |
| 52 Week Range | 37.31 - 50.08 |
About
Amsterdam
Noord Holland
1096 BC
Koninklijke Philips NV dividends
Total Valuation
Koninklijke Philips N.V. has a market cap or net worth of €37.40 billion. The enterprise value is €0.
Important Dates
Share Statistics
Koninklijke Philips N.V. has 0.92 billion shares outstanding.
Valuation Ratios
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Koninklijke Philips N.V.'s PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.0521%. The beta is 0.0000, so Koninklijke Philips N.V.'s price volatility has been lower than the market average.
Income Statement
In the last 12 months, Koninklijke Philips N.V. had revenue of €0 and earned €0 in profits. Earnings per share was €.
About
Amsterdam
Noord Holland
1096 BC
Company Description
Royal Philips is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries..